Quality assurance of drugs used in clinical trials: proposal for adapting guidelines
@inproceedings{Newton2015QualityAO, title={Quality assurance of drugs used in clinical trials: proposal for adapting guidelines}, author={Paul N Newton and David M Schellenberg and Elizabeth A Ashley and Raffaella Ravinetto and Michael David Green and Feiko O Ter Kuile and Patricia Tabernero and Nicholas J White and Philippe J Guerin}, booktitle={BMJ}, year={2015} }
Topics from this paper.
Citations
Publications citing this paper.
SHOWING 1-9 OF 9 CITATIONS
Combating poor-quality anti-malarial medicines: a call to action
VIEW 7 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED
Assessing the quality of anti-malarial drugs from Gabonese pharmacies using the MiniLab®: a field study
VIEW 3 EXCERPTS
CITES METHODS
HIGHLY INFLUENCED
Innovación tecnológica y financiación de prestaciones
VIEW 1 EXCERPT
Prospects and strategies for malaria elimination in the Greater Mekong Sub-region: a qualitative study
VIEW 1 EXCERPT
CITES BACKGROUND
Scarce quality assurance documentation in major clinical trial registries for approved medicines used in post-marketing clinical trials
VIEW 3 EXCERPTS
CITES BACKGROUND & METHODS
Tackling the Problems Associated with Antimalarial Medicines of Poor Quality
VIEW 2 EXCERPTS
CITES BACKGROUND
References
Publications referenced by this paper.
SHOWING 1-10 OF 17 REFERENCES